InvestorsHub Logo
Followers 183
Posts 11456
Boards Moderated 0
Alias Born 01/25/2010

Re: None

Thursday, 01/22/2015 1:36:06 PM

Thursday, January 22, 2015 1:36:06 PM

Post# of 1396
On MEIP's CEO Dan Gold, who helped turn around this biotech firm, see this old post from Yahoo MB:

sherekhan100 • Oct 26, 2013 1:40 PM

After the Phenoxodiol OVATURE disaster, MEI Pharma (previously Marshall Edwards) probably would not exist today if not for Dan Gold. In the 3 years since joining the Company, Gold has accomplished the following:

- Figured out where and how the Company had gone wrong with OVATURE. Previous management ran a PIII trial that used oral delivery formulation when previous trials showing efficacy used IV delivery.

- Brought in a competent team and well-respected board members.

- Obtained a following and buy recommendations from recognized biotech analysts.

- Efficiently moved ME-344 and ME-143 through Phase I trials

- Brought in Procinostat, which is a potential grand slam hematological compound that he obtained for peanuts.

- Has successfully raised money from recognized funds and biotech investors when needed at each step.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MEIP News